AI
UTMD icon

Atria Investments’s Utah Medical Products UTMD Stock Holding History

Atria Investments’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$306K Buy
4,932
+7
+0.1% +$441 ﹤0.01% 1744
2025
Q4 		$276K Sell
4,925
-162
-3% -$9.39K ﹤0.01% 1783
2025
Q3 		$320K Sell
5,087
-1,316
-21% -$77.8K ﹤0.01% 1684
2025
Q2 		$364K Sell
6,403
-3,550
-36% -$193K ﹤0.01% 1595
2025
Q1 		$558K Buy
9,953
+1,054
+12% +$63.1K 0.01% 1293
2024
Q4 		$547K Buy
8,899
+1,712
+24% +$111K 0.01% 1281
2024
Q3 		$481K Sell
7,187
-62
-0.9% -$4.21K 0.01% 1339
2024
Q2 		$484K Buy
+7,249
New +$493K 0.01% 1320

Other funds holding UTMD

BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MA
Minerva Advisors Bala Cynwyd, Pennsylvania $155M AUM 35.49% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Atria Investments's UTMD Position: Q1 2026 in Review

Atria Investments increased its Utah Medical Products (UTMD) stake by 0.14% in Q1 2026, buying an estimated $441 and bringing the position to 4,932 shares worth $306K. The position accounts for ﹤0.01% of the portfolio, ranked #1744.

Atria Investments first reported a position in UTMD in Q2 2024 and has held it in 8 quarters since. The position peaked at $558K in Q1 2025. 119 funds tracked by Wall St. Rank hold UTMD as of Q1 2026.

  • Atria Investments held 4,932 shares of Utah Medical Products worth $306K as of Q1 2026.
  • Atria Investments bought 7 Utah Medical Products shares in Q1 2026, an estimated $441.
  • Utah Medical Products made up ﹤0.01% of Atria Investments's portfolio in Q1 2026, its #1744 holding.
  • Atria Investments first reported a position in Utah Medical Products in Q2 2024 and has held it in 8 quarters since.
  • Atria Investments's Utah Medical Products position peaked at $558K in Q1 2025.
  • 119 funds tracked by Wall St. Rank held Utah Medical Products as of Q1 2026.

Based on Atria Investments's 13F filing for Q1 2026, filed 5 May 2026.